Evolus (EOLS) Non-Current Deferred Tax Liability (2017 - 2026)
Evolus (EOLS) reported Non-Current Deferred Tax Liability of $23000.0 for Q1 2026, up 1050.0% on a YoY basis from $2000.0 in Q1 2025, and down 17.86% quarter-over-quarter from $28000.0 in Q4 2025.
Evolus (EOLS) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Evolus has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $23000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 1050.0% year-over-year to $23000.0; the trailing twelve-month figure through Mar 2026 stood at $23000.0 (up 1050.0% YoY), and the FY2025 full-year result was $28000.0, up 366.67% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $23000.0, down from $28000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $12.4 million in Q4 2022, with the low at $2000.0 in Q1 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $1.4 million across 5 years, with a median of $24000.0 in 2022.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability slumped 99.93% — and 2026, when it surged 1050.0%.
- Evolus' Non-Current Deferred Tax Liability stood at $12.4 million in 2022, then fell by 25.68% to $9.2 million in 2023, then tumbled by 99.93% to $6000.0 in 2024, then jumped by 366.67% to $28000.0 in 2025, then retreated by 17.86% to $23000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $23000.0 (Q1 2026), $28000.0 (Q4 2025), and $21000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 9.19 Mn |
| Dec 31, 2023 | 9.19 Mn |
| Sep 30, 2023 | 22,000.00 |
| Sep 30, 2023 | 22,000.00 |